Human monoclonal antibodies that bind human insulin like...

Details Human monoclonal antibodies that bind human insulin like... Human monoclonal antibodies that bind human insulin like...

2007-04-06

2011-12-06

Dent, Alana Harris (Department: 1643)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S007100, C435S007200, C435S007210, C435S040520, C435S069600, C435S335000, C435S320100, C436S501000, C436S503000, C436S063000, C436S064000, C530S387100, C530S387300, C530S388100, C530S388150, C530S388240, C530S388800, C530S388850, C530S391100, C530S391300, C536S023500, C424S001490, C424S009340, C424S009341, C424S130100, C424S133100, C424S134100, C424S141100, C424S142100, C424S145100, C424S156100

Reexamination Certificate

active

08071323

ABSTRACT:
Antibody compositions and methods for treatment of neoplastic disease in a mammalian subject are provided. Methods of diagnosing cancer in a mammalian subject are also provided.

REFERENCES:
patent: 3791932 (1974-02-01), Schuurs et al.
patent: 3817837 (1974-06-01), Rubenstein et al.
patent: 3839153 (1974-10-01), Schuurs et al.
patent: 3850578 (1974-11-01), McConnell
patent: 3850752 (1974-11-01), Schuurs et al.
patent: 3853987 (1974-12-01), Dreyer
patent: 3867517 (1975-02-01), Ling
patent: 3879262 (1975-04-01), Schuurs et al.
patent: 3901654 (1975-08-01), Gross
patent: 3935074 (1976-01-01), Rubenstein et al.
patent: 3939350 (1976-02-01), Kronick et al.
patent: 3984533 (1976-10-01), Uzgiris
patent: 3996345 (1976-12-01), Ullman et al.
patent: 4034074 (1977-07-01), Miles
patent: 4098876 (1978-07-01), Piasio et al.
patent: 4275149 (1981-06-01), Litman et al.
patent: 4277437 (1981-07-01), Maggio
patent: 4366241 (1982-12-01), Tom et al.
patent: 4376110 (1983-03-01), David et al.
patent: 4391904 (1983-07-01), Litman et al.
patent: 4399216 (1983-08-01), Axel et al.
patent: 4486530 (1984-12-01), David et al.
patent: 4681581 (1987-07-01), Coates
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4735210 (1988-04-01), Goldenberg
patent: 4740461 (1988-04-01), Kaufman
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4912040 (1990-03-01), Kaufman et al.
patent: 4959455 (1990-09-01), Clark et al.
patent: 5101827 (1992-04-01), Goldenberg
patent: 5102990 (1992-04-01), Rhodes
patent: 5194594 (1993-03-01), Khawli et al.
patent: 5401629 (1995-03-01), Harpold et al.
patent: 5436128 (1995-07-01), Harpold et al.
patent: 5530101 (1996-06-01), Queen et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5591669 (1997-01-01), Krimpenfort et al.
patent: 5612205 (1997-03-01), Kay et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5625825 (1997-04-01), Rostoker et al.
patent: RE35500 (1997-05-01), Rhodes
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5643763 (1997-07-01), Dunn et al.
patent: 5648471 (1997-07-01), Buttram et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5693761 (1997-12-01), Queen et al.
patent: 5693792 (1997-12-01), Torii et al.
patent: 5697902 (1997-12-01), Goldenberg
patent: 5703057 (1997-12-01), Johnston et al.
patent: 5714350 (1998-02-01), Co et al.
patent: 5721367 (1998-02-01), Kay et al.
patent: 5733743 (1998-03-01), Johnson et al.
patent: 5741957 (1998-04-01), Deboer et al.
patent: 5750172 (1998-05-01), Meade et al.
patent: 5756687 (1998-05-01), Denman et al.
patent: 5770429 (1998-06-01), Lonberg et al.
patent: 5777085 (1998-07-01), Co et al.
patent: 5789215 (1998-08-01), Berns et al.
patent: 5789650 (1998-08-01), Lonberg et al.
patent: 5814318 (1998-09-01), Lonberg et al.
patent: 5827690 (1998-10-01), Meade et al.
patent: 5914241 (1999-06-01), Valkirs
patent: 5939598 (1999-08-01), Kucherlapati et al.
patent: 5965375 (1999-10-01), Valkirs
patent: 6075181 (2000-06-01), Kucherlapati et al.
patent: 6114598 (2000-09-01), Kucherlapati et al.
patent: 6150584 (2000-11-01), Kucherlapati et al.
patent: 6162963 (2000-12-01), Kucherlapati et al.
patent: 6673986 (2004-01-01), Kucherlapati et al.
patent: 7064244 (2006-06-01), Kucherlapati et al.
patent: 0 323 997 (1988-07-01), None
patent: 0 256 055 (1991-08-01), None
patent: 0 338 841 (1995-03-01), None
patent: 0 216 846 (1995-04-01), None
patent: 0 463 151 (1996-06-01), None
patent: 0 546 073 (1997-09-01), None
patent: 1 505 075 (2005-02-01), None
patent: WO 91/17271 (1991-11-01), None
patent: WO 92/01047 (1992-01-01), None
patent: WO 92/03918 (1992-03-01), None
patent: WO 92/22645 (1992-12-01), None
patent: WO 92/22647 (1992-12-01), None
patent: WO 92/22670 (1992-12-01), None
patent: WO 93/06213 (1993-04-01), None
patent: WO 93/12227 (1993-06-01), None
patent: WO 94/00569 (1994-01-01), None
patent: WO 94/02602 (1994-02-01), None
patent: WO 94/25585 (1994-11-01), None
patent: WO 94/29444 (1994-12-01), None
patent: WO 96/14436 (1996-05-01), None
patent: WO 96/34096 (1996-10-01), None
patent: WO 97/08320 (1997-03-01), None
patent: WO 97/13852 (1997-04-01), None
patent: WO 97/38137 (1997-10-01), None
patent: WO 98/24884 (1998-06-01), None
patent: WO 98/24893 (1998-06-01), None
patent: WO 00/37504 (2000-06-01), None
patent: WO 01/14424 (2001-03-01), None
patent: WO03093317 (2003-11-01), None
patent: WO 03/100008 (2003-12-01), None
patent: WO 2004/092219 (2004-10-01), None
Paul, William E. Fundamental Immunology, 3rd Edition, Raven Press, New York, Chapt. 8, pp. 242, 292-295, 1993.
Rudikoff et al. Proc. Natl. Acad. Sci. USA, 79(6):1979-1983, Mar. 1982.
Colman P. M. Research in Immunology, 145:33-36, 1994.
Bendig M. M. Methods: A Companion to Methods in Enzymology, 8:83-93, 1995.
MacCallum et al. J. Mol. Biol., 262, 732-745, 1996.
Casset et al. Biochemical and Biophysical Research Communications, 307:198-205, 2003.
Belagaje R, et al., Total synthesis of a tyrosine suppressor transfer RNA gene. XIV. Chemical synthesis of oligonucleotide segments corresponding to the terminal regions. J Biol Chem. Jul. 10, 1979;254(13):5765-80.
Bird RE, et al., Single-chain antigen-binding proteins. Science. Oct. 21, 1988;242(4877):423-6. Erratum in: Science Apr. 28, 1989;244(4903):409.
Blake J, Litzi-Davis L. Evaluation of peptide libraries: an iterative strategy to analyze the reactivity of peptide mixtures with antibodies. Bioconjug Chem. Nov.-Dec. 1992;3(6):510-3.
Bowie JU, et al., A method to identify protein sequences that fold into a known three-dimensional structure. Science. Jul. 12, 1991;253(5016):164-70.
Burtrum D et al. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo. Cancer Res. Dec. 15, 2003;63(24):8912-21.
Cevc G, et al., Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta. Jan. 19, 1998;1368(2):201-15.
Chaudhary VK, et al., A rapid method of cloning functional variable-region antibody genes inEscherichia colias single-chain immunotoxins. Proc Natl Acad Sci U S A. Feb. 1990;87(3):1066-70. Erratum in: Proc Natl Acad Sci U S A Apr. 1990;87(8):3253.
Chen SY, et al., Intracellular antibodies as a new class of therapeutic molecules for gene therapy. Hum Gene Ther. May 1994;5(5):595-601.
Chiswell DJ, McCafferty J. Phage antibodies: will new ‘coliclonal’ antibodies replace monoclonal antibodies? Trends Biotechnol. Mar. 1992;10(3):80-4.
Chothia C, et al., Conformations of immunoglobulin hypervariable regions. Nature. Dec. 21-28, 1989;342(6252):877-83.
Chothia C, Lesk AM. Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol. Aug. 20, 1987;196(4):901-17.
Cwirla SE, et al., Peptides on phage: a vast library of peptides for identifying ligands. Proc Natl Acad Sci U S A. Aug. 1990;87(16):6378-82.
Dranoff G, et al., Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci U S A. Apr. 15, 1993;90(8):3539-43.
Evans BE, et al., Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists. J Med Chem. Jul. 1987;30(7):1229-39.
Fanger MW, et al., Production and use of anti-FcR bispecific antibodies. Immunomethods. Feb. 1994;4(1):72-81.
Fauchere, Elements for the Rational Design of Peptide Drugs. J. Adv. Drug Res., 1986, 15:29.
Felici F, et al., Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector. J Mol Biol. Nov. 20, 1991;222(2):301-10.
Fry DW, et al., Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor. Proc Natl Acad Sci U S A. Sep. 29, 1998;95(20):12022-7.
Fundamental Immunology, Ch. 7 (

Affiliated with

Also associated with

Rating

Human monoclonal antibodies that bind human insulin like... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human monoclonal antibodies that bind human insulin like..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human monoclonal antibodies that bind human insulin like... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4296555